Form 4 for ZTS Zoetis
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-16 · accession 0001555280-22-000118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-18 | 2022-03-16 | ZTS | Trawicki Roman | EVP | S - Sale+OE | $188.15 | -6,000 | 8,218 | -42% | -$1.13M |
| D | 2022-03-18 | 2022-03-16 | ZTS | Trawicki Roman | EVP | M - OptEx | $87.51 | +6,000 | 14.2K | +73% | +$525.1K |
| D | 2022-03-18 | 2022-03-16 | ZTS | Trawicki Roman | EVP | M - OptEx | $0.00 | -6,000 | 33.9K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-16 | S | D | 6,000 | $188.15 | 8,218 | D | — | — | (F1) The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2022-03-16 | M | A | 6,000 | $87.51 | 14,218 | D | — | — | |
| 3 | Derivative | Stock Option | 2022-03-16 | M | D | 6,000 | $0.00 | 33,941 | D | — · — to — | 6,000 Common Stock | (F2) Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. (F6) 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option. (F3) 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option. (F4) Each option vests on the third anniversary of the date of grant. (F5) Each option expires on the tenth anniversary of the date of grant. |